Impact of Iron Deficiency on Reproductive Health and Quality on Life

DURATION OF ACTIVITY

October 10, 2022 through November 30, 2022

LEARNING OBJECTIVES

• Utilize evidence-based practice related to iron deficiency and iron deficiency anemia (ID/IDA) in reproductive aged women, including those who are pregnant

• Implement evaluation and management strategies informed by clinical differentiators and patient preferences related to the treatment of women with ID/IDA

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME and Women’s Health research Collaborative (WHrC).  MedicusCME is accredited by the ACCME to provide continuing medical education for physicians. 

DESIGNATION STATEMENT

MedicusCME designates this Internet Enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

DISCLOSURE OF FINANCIAL RELATIONSHIPS

MedicusCME requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to MedicusCME policy. 

Malcolm Munroe, MD has disclosed a financial relationship with Daiichi Sankyo, Pharmacosmos, Shield Therapeutics for his role as consultant.

All other faculty and planners, as well as MedicusCME planners and managers, have no relevant financial relationships with ineligible companies to disclose. All relevant financial relationships disclosed by planners or content contributors have been mitigated according to MedicusCME policies. 

ACKNOWLEDGEMENTS
This activity is supported by an independent medical education (IME) grant from Pharmacosmos.

ESTIMATED TIME TO COMPLETE ACTIVITY: 1 hour

COURSE FORMAT/MEDIUM: Internet Activity (Enduring Material)

HOW TO CLAIM CREDIT

In order to receive AMA PRA Category 1 credit™, participants must do the following: 

• Review the learning objectives and faculty disclosures.

• Participate in the webinar and review any resources and support materials provided

• Complete the post-test and achieve a score of 80% or higher

• Complete the CME evaluation and indicate the amount of credit claimed, participant’s date of birth, licensing state and license number 

HIPPA COMPLIANCE ATTESTATION

In accordance with the Health Insurance Portability and Accountability Act (HIPAA), this educational activity, especially when utilizing patient cases for learning demonstration, will not include individually identifiable health information.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.